جستجوی استاد راهنمای دانشگاهی

Professor Chris Holmes is a Professor of Biostatistics at the University of Oxford, where he moved from Imperial College London in February 2004. He is a Fellow at St Anne's College and works in the Department of Statistics. His research focuses on applications and statistical methods development in genomic sciences and genetic epidemiology, holding a prestigious Programme Leaders Grant in Statistical Genomics from the Medical Research Council. Prior to his position at Oxford, Professor Holmes completed his doctorate in Bayesian statistics at Imperial College London, investigating novel nonlinear pattern recognition methods. This was followed by a post-doctoral position and then a lectureship at Imperial. Before his academic career, he worked in industry for several years in scientific computing, developing techniques for real-time pattern recognition models in defense and SCADA systems. Professor Holmes has a broad interest in the theory, methods and applications of statistics and statistical modeling, with a particular foundation in Bayesian statistics which he views as providing a unified framework for stochastic modeling and information processing. His specific research interests include: Bayesian statistics and stochastic simulation Markov chain Monte Carlo methods Pattern recognition and nonlinear, nonparametric methods Spatial statistics Statistical genetics and genomics Genetic epidemiology His recent publications (2023-2025) demonstrate a strong focus on the intersection of biostatistics, artificial intelligence, and healthcare applications. His work spans multiple domains including AI-driven disease classification in neurology, genomic data analysis for health equity, machine learning tools for healthcare prediction, and addressing bias in medical AI systems. A notable trend across his research is the application of advanced statistical methods to solve pressing problems in genomics, epidemiology, and medical diagnostics, with an increasing emphasis on health equity and the ethical implications of AI in healthcare. Professor Holmes currently supervises PhD students Oscar Clivio, Sahra Ghalebikesabi, and Natalia Garcia Martin. His research is supported by multiple grants, including the MRC Programme Leaders Grant in Statistical Genomics which funds his work in statistical genomics. He is actively involved in three research groups at Oxford that reflect the breadth of his scholarly interests: Computational Statistics and Machine Learning Statistical Genetics and Epidemiology Statistical Theory and Methodology

• Bayesian statistics
• Stochastic simulation
• Markov chain Monte Carlo
• +۵ مورد دیگر

Dr. Samira Lakhal-Littleton is an Associate Professor of Cell Physiology and MRC Senior Non-Clinical Research Fellow at the University of Oxford, affiliated with the Department of Physiology, Anatomy and Genetics and Brasenose College. Her research focuses on iron homeostasis, systems biology, and oxygen sensing mechanisms in cardiovascular and systemic physiology. Education: BSc in Human Genetics (University College London), DPhil in Molecular Medicine (University of Oxford) Her work bridges cell physiology and translational medicine, with key discoveries on hypoxia-inducible factors (HIFs), iron regulatory genes TMPRSS6 and GDF15 , and the role of hepcidin in altitude adaptation and chronic diseases. She utilizes tissue-specific animal models to study iron regulation in heart, kidney, placenta, and vasculature. Recent publications highlight her contributions to understanding: FLASH radiotherapy effects linked to iron-dependent lipid peroxidation Clinical implications of myocardial iron dynamics in heart failure Hepcidin's role in vascular protection and placental iron transfer Biomarker development for predictive iron deficiency diagnostics Scientific Leadership: British Heart Foundation Intermediate Fellowship (2012) MRC Senior Fellowship (2020) BioIron Society Board Member (2019) She collaborates with clinical teams on translational projects and serves as a Tutorial Fellow in Medicine at Brasenose College, mentoring students in physiological sciences.

• Iron Homeostasis
• Cell Physiology
• Systems Biology
• +۴ مورد دیگر

Dr. Liam Mannion is a Senior Lecturer in Therapeutic Radiography and Oncology at City St George’s, University of London, where he leads key modules in radiotherapy techniques, oncology, and radiobiology. He is an HCPC-registered Therapeutic Radiographer with clinical experience in both NHS and private sectors. He also serves as the Practice Education Lead for Therapeutic Radiography and is a Senior Fellow of the Higher Education Academy. PhD, King's College London MSc, London South Bank University PGCert, City, University of London BSc (Hons), University College Dublin His research focuses on optimizing treatments for muscle-invasive bladder cancer, patient-centered care, and radiobiology. He employs methodologies such as discrete choice experiments to understand patient preferences in treatment decisions. His educational interests include gamification, debriefing, and student well-being in radiography training. His recent publications reveal a strong trend in patient-centered oncology research, particularly in bladder cancer decision-making, alongside innovations in radiotherapy education. He frequently collaborates with institutions like King's College London and Guy's and St Thomas' NHS Foundation Trust. Dr. Mannion is actively involved in peer review for the Journal of Radiotherapy in Practice and served as an External Examiner at Cardiff University. He has also held leadership roles such as Joint Programme Director at City, University of London. He has contributed to research on compassion fatigue among students, leadership in radiography during the pandemic, and functional imaging in glioblastoma. His work bridges clinical practice, education, and patient-centered outcomes. Dr. Mannion is affiliated with professional organizations including the Health and Care Professions Council (HCPC) and the Society of Radiographers. He teaches across undergraduate modules in radiotherapy and oncology, with a focus on practical and theoretical integration.

• Radiobiology
• Therapeutic Radiography
• Oncology
• +۷ مورد دیگر

Professor Ananya Choudhury serves as Chair and Honorary Consultant in Clinical Oncology at the University of Manchester, where she is also Co-Group Leader of the Translational Radiobiology Group within the Division of Cancer Sciences. She joined The Christie NHS Foundation Trust in 2008, specializing in urology and sarcoma, and has since focused on radiotherapy-related research in prostate and bladder cancers. Professor Choudhury is clinical lead for advanced radiotherapy, including the groundbreaking MRLinac project, and plays a key role in national radiotherapy research initiatives. Professor Choudhury earned her BA (Hons) in 1993, MB. BChir (Cantab) in 1995, and MA (Cantab) in 1997 from Trinity College, Cambridge. She completed her Clinical Oncology training at the Yorkshire Deanery from 2000-2008, during which she earned her MRCP in 2000 and F.R.C.R in 2004. She completed her PhD in 2008 through the University of Leeds and Princess Margaret Hospital in Toronto, Canada, where she studied the molecular epidemiology of DNA double strand break repair in bladder cancer. Professor Choudhury's research program focuses on optimizing and personalizing radiotherapy using advanced imaging technology to deliver high doses while minimizing side effects. Her work centers on prostate and bladder cancers, with particular interest in predictive biomarkers, hypoxia, and the integration of magnetic resonance imaging to improve treatment precision. She has pioneered research in radiotherapy dose optimization, biomarker development, and the identification of patients who would benefit most from different treatment approaches. Her extensive publication record demonstrates a strong focus on radiation therapy, particularly in genitourinary cancers. Recent work explores MRI-guided radiotherapy, hypoxia biomarkers, and personalized treatment approaches across multiple cancer types. She has made significant contributions to understanding how imaging technology can improve radiotherapy precision and effectiveness while reducing side effects, with several publications appearing in top journals through 2025. Professor Choudhury has received multiple prestigious awards recognizing her contributions to the field: Cancer Research-UK/Royal College of Radiologists Clinical Training Fellowship (2005) Fellowship for the 10th ECCO-AACR-ASCO Workshop on Methods in Clinical Cancer Research (2007) Outstanding Contribution, Greater Manchester Clinical Research Awards (2017) RCR Research Fellowship (2005) Research Fellowship, Princess Margaret Hospital, Toronto (2004) Professor Choudhury has supervised numerous doctoral and master's students across multiple cancer types, with current students expected to complete through 2024. She is Principal Investigator on multiple research grants, including 'Measuring tumour radioresistance to improve radiotherapy outcomes' and the 'MAESTRO Programme' as part of CRUK RadNet. Her research program is supported by significant funding from NIHR Manchester Biomedical Research Centre and other major funding bodies. As Co-Group Leader of the Translational Radiobiology Group, Professor Choudhury collaborates extensively with leading researchers including Peter Hoskin, Catharine West, Corinne Faivre-Finn, and Marcel van Herk. Her team is at the forefront of integrating advanced imaging with radiotherapy to improve cancer treatment outcomes, with active projects spanning from basic radiobiology to clinical implementation of novel radiotherapy techniques.

• Radiation Therapy
• Prostate Cancer
• Bladder Cancer
• +۹ مورد دیگر

Björn Ross is a Lecturer in Computational Social Science at the University of Edinburgh's School of Informatics, where he is affiliated with the Institute for Language, Cognition and Computation. He serves as Director of the SMASH research group and is part of the management team for the Centre for Doctoral Training in Natural Language Processing (CDT in NLP). His educational background includes: PhD (2019) from the University of Duisburg-Essen MSc in Computer Science (2016) from the University of Münster Exchange year (2014-2015) at the University of Strasbourg BSc in Information Systems (2013) from the University of Münster Ross's research focuses on computational social science, particularly using natural language processing, social network analysis, and agent-based modeling to study social media phenomena. His work examines misinformation, hate speech, bot activity, and the ethical implications of computational methods. He also investigates how social media can be leveraged for social good, especially in crisis communication contexts. A significant portion of his recent research addresses bias and fairness issues in AI systems, particularly regarding marginalized communities and LGBTQ+ identities. His work spans both technical development of computational methods and critical examination of their societal impacts. Analysis of his recent publications reveals a strong trend toward examining bias in AI systems, particularly regarding marginalized communities. His work spans multiple methodologies including computational analysis of social media data, development of NLP techniques, and critical examination of AI ethics. He frequently collaborates across disciplines, working with researchers in computer science, social sciences, and healthcare domains. His professional recognition includes: Best Paper Award at the Hawaii International Conference on System Sciences (HICSS) in 2018 Associate Editor for Business & Information Systems Engineering Active membership in professional organizations including AIS, ACL, and ACM Ross currently supervises multiple PhD students including Agostina Calabrese, Eddie Ungless, Sandrine Chausson, Wendy Zheng, Seraphina Goldfarb-Tarrant, and Mahmoud Ibrahim. At the University of Edinburgh, he teaches courses such as 'Text Technologies for Data Science' and 'Evidence, Argument and Persuasion in a Digital Age,' reflecting his expertise at the intersection of computational methods and social implications.

• Computational social science
• Social computing
• Information systems
• +۹ مورد دیگر

Geoff Higgins is a Professor of Clinical Oncology at the University of Oxford, where he leads the Higgins Group in the Department of Oncology. He is also the Malcolm & Margaret Howat Professor of Clinical Oncology and an Honorary Consultant Clinical Oncologist at Oxford University Hospitals NHS Trust. His research focuses on enhancing radiotherapy efficacy through laboratory and clinical investigations, including repurposing existing compounds and developing novel treatments. MBChB, MRCP, FRCR, DPhil Pharmacology & Medicine, University of Edinburgh (1997-2000) Research Interests: Higgins' work addresses the tumor microenvironment, particularly hypoxia and genomic instability in cancer cells. His team explores combination therapies with radiotherapy, such as mitochondrial inhibitors and Polθ-targeting agents, aiming to translate discoveries into clinical trials with functional imaging and genomic monitoring. Key Publications: Recent studies highlight his group's breakthroughs in radiosensitization mechanisms, including Polθ inhibition for BRCA-deficient cancers and Atovaquone's role in tumor oxygenation. These works span disciplines from molecular biology to clinical translation. Honors: Clinician Scientist Fellowship (Cancer Research UK) Advanced Clinician Scientist Fellowship (Cancer Research UK) Royal College of Radiologists/CRUK Clinical Research Fellowship Academic Leadership: Higgins supervises DPhil and MRes students while mentoring postdoctoral researchers. Former trainees now hold prestigious roles at institutions like Memorial Sloan Kettering Cancer Center and Harvard University. His collaborative network includes the CRUK National Cancer Imaging Translational Accelerator, where he serves as joint-lead investigator.

• Radiation Oncology
• Cancer Biology
• Tumor Microenvironment
• +۳ مورد دیگر

Dr David Cutter is a Clinical Research Fellow at the University of Oxford's Clinical Trial Service Unit (CTSU) and a Consultant Clinical Oncologist at the Oxford Cancer Centre . His career spans clinical practice and academic research, focusing on the late effects of cancer treatments. Education: Medicine at the University of Cambridge (1994-2000) DPhil: Late cardiovascular effects of cancer treatments (CTSU, 2008) Current Role: Investigating benefits and risks of cancer therapies since 2013 His research bridges Oncology , Cardiovascular Toxicity , and Radiation Therapy , with significant contributions to understanding cardiotoxicity in lymphoma survivors. Recent publications include studies on Proton Beam Therapy , Bleomycin Pulmonary Toxicity , and Cardiovascular Disease Incidence in cancer patients. Key trends in his work include: Cardiovascular Risk Assessment in cancer survivors Proton Therapy Optimization for lymphoma Geographic Health Inequity in clinical trial access His 15 most recent publications (2022-2025) cover topics such as radiation dose prediction models, second cancer risks, and guideline development for classical Hodgkin lymphoma management. The work frequently involves multidisciplinary collaborations, including with the European Society of Cardiology and British Society for Haematology.

• Clinical Oncology
• Cardiovascular Toxicity
• Radiotherapy
• +۳ مورد دیگر

Dr. Rainer Hinz is a Senior Lecturer in Functional Imaging at the University of Manchester, affiliated with the Division of Informatics, Imaging & Data Sciences within the Research School of Cancer and Enabling Sciences. He specializes in developing and applying positron emission tomography (PET) techniques for radiation therapy monitoring, oncology, neurology, and psychiatry research. Education: Diplom-Ingenieur (Electrical Engineering) from Chemnitz University of Technology (1995) Doktor-Ingenieur (Biomedical Engineering) from Dresden University of Technology (2000) Research focuses on PET methodologies for disease progression monitoring, particularly in Alzheimer’s, multiple sclerosis, and oncological applications. He contributes to advancing PET imaging standards, collaborating on projects like the CRUK Imaging Centres. His work aligns with UN SDGs related to health and innovation. Publications emphasize neuroinflammation biomarkers, PET tracer applications, and imaging analytics. He actively supervises postgraduate research and contributes to interdisciplinary grants and teaching in advanced imaging techniques.

• Positron Emission Tomography (PET)
• Radiation Therapy
• Neuroinflammation
• +۴ مورد دیگر

Dr. Ram Bajpai is a Lecturer in Epidemiology/Applied Statistics at Keele University's School of Medicine. He joined in 2019 as part of the Research Institute for Primary Care and Health Sciences, combining active research and teaching roles. Previously, he worked at the Lee Kong Chian School of Medicine (Nanyang Technological University, Singapore) and the Army College of Medical Sciences (India). Education: BSc in Statistics/Mathematics (University of Lucknow), MSc Health Statistics (Banaras Hindu University), PhD in Medical Statistics (Guru Gobind Singh Indraprastha University). Research focuses on cross-domain applications of statistical/epidemiological methods, including survival analysis, Bayesian methods, risk prediction modelling, and evidence synthesis. Teaching experience includes biostatistics modules for medical students at multiple institutions. Current research interests span prognostic studies, meta-analysis, complex data analysis, and design of epidemiological studies. Key contributions include systematic reviews on gout prophylaxis safety, dementia prognostic factors, and long-term outcomes of pediatric COVID-19. Active in collaborative projects on aging populations, musculoskeletal health, and public health interventions.

• Epidemiology
• Biostatistics
• Survival Analysis
• +۷ مورد دیگر

Professor Carsten Welsch is a leading physicist in accelerator science and technology at the University of Liverpool. He founded the QUASAR Group in 2008 and served as Head of the Physics Department from 2016 to 2023. His work bridges cutting-edge research in antimatter physics, beam diagnostics, and innovative accelerator design with strategic leadership in education and international collaboration. PhD in Accelerator Physics, University of Frankfurt Postdoc, Max Planck Institute for Nuclear Physics CERN Fellow (2005) His research focuses on low-energy antimatter physics , plasma wakefield acceleration , and dielectric laser accelerators , with applications in medicine and global challenges. Recent publications highlight advancements in betatron radiation modeling, positronium cooling, and plasma-driven acceleration techniques. He has secured over 25M€ in EU funding for networks like AVA and EuPRAXIA, trained 100+ Marie Curie Fellows, and founded D-Beam Ltd for beam instrumentation. Awards include the Viddy Platinum Award (2022) and Helmholtz-University YIG Award (2006). As Director of the LIV.INNO Center for Doctoral Training, he champions data-intensive science education. His outreach efforts have impacted millions globally, emphasizing discovery science and accelerator technology's societal benefits.

• Accelerator Physics
• Antimatter Physics
• Beam Instrumentation
• +۶ مورد دیگر

Helen Byrne is a Professor of Applied Mathematics at the University of Oxford and a Tutorial Fellow at Keble College. Her academic roles include former Examiner for Final Honour School Mathematics, Associate Head of Department for Planning and Equality and Diversity, and Director of Equality and Diversity in the university’s MPLS Division. DPhil MSc BA/MA Her research focuses on developing mathematical and computational models to study biomedical systems, particularly solid tumours, wound healing, and tissue engineering. She aims to uncover mechanisms behind biological phenomena and derive novel mathematical insights from these models. Recent publications highlight her work in tumor-immune interactions, atherosclerosis, antibody dynamics, and radiation therapy, employing techniques like spatial modeling, agent-based simulations, and multiscale approaches. Her research bridges theoretical mathematics and practical biomedical challenges. 2019: Leah Edelstein-Keshet Prize (Senior Award), Society for Mathematical Biology 2020: Fellow of the Society for Mathematical Biology Helen Byrne has supervised numerous students and researchers, contributing to mathematical biology and biomedical modeling. Her teaching includes courses on multivariable calculus, applied partial differential equations, and advanced mathematical biology.

• Mathematical Biology
• Computational Biology
• Tumour Modeling
• +۵ مورد دیگر

Dr. Daniel R Obaid is a Clinical Associate Professor and Consultant Cardiologist at Swansea University Medical School , specializing in Biomedical Sciences . His clinical academic work at the Morriston Regional Cardiac Centre and ILS 2 Clinical Imaging Facility focuses on advanced cardiovascular imaging and interventional cardiology. Expertise in Interventional Cardiology , Cardiac CT , and Atherosclerotic Plaque Imaging Significant contributions to patient safety and human factors in cardiovascular procedures Recipient of the Young Investigator Prize from the Society of Cardiovascular CT, USA His research integrates invasive and non-invasive imaging techniques to identify vulnerable plaques, with publications spanning atherosclerosis , clot microstructure , and AI applications in cardiology . Current studies include virtual TAVR simulations and biomechanical analysis of plaque stress . Recent collaborative work explores low-dose radiation protocols , LDL transport modeling , and anti-inflammatory effects of GLP-1 agonists , reflecting interdisciplinary approaches to cardiovascular risk mitigation. Available for postgraduate supervision , Dr. Obaid has contributed to undergraduate medical professionalism and cardiovascular physiology modules (PM-241F, PM-266).

• Interventional Cardiology
• Cardiac Computed Tomography
• Intravascular Imaging
• +۵ مورد دیگر

Professor Reinhold J. Medina serves as Chair Professor of Vision and Vascular Science and Head of the Department of Eye and Vision Science at the University of Liverpool's Institute of Life Course and Medical Sciences, leading research in vascular biology with emphasis on vascular ageing, diabetes complications, and regenerative mechanisms. Educational milestones include an MD from San Agustin University-Arequipa (2000) and a PhD in Stem Cell Biology from Okayama University Medical School (2006), followed by clinical training in Peru and postdoctoral work in Japan before joining Queen's University Belfast. His research program integrates cell and molecular biology to investigate endothelial progenitor cell function in diabetic retinopathy, vascular repair mechanisms, and ageing-related pathologies, with international recognition for advancing understanding of vascular dysfunction in ocular diseases. Current work focuses on metabolic regulation in endothelial cells and senescence pathways in age-related macular degeneration. Recent publications demonstrate strong interdisciplinary convergence across ophthalmology, vascular biology, and gerontology, with recurring themes in metabolic dysregulation (glycolysis), oxidative stress (NOX4), cellular senescence, and translational applications for diabetic complications and retinal diseases. Key scientific awards include: Juvenile Diabetes Research Foundation International Postdoctoral Fellowship (2008) Fight for Sight Postdoctoral Fellowship (2010) Active research grants drive innovation in dry AMD treatment through choriocapillaris senescence targeting (Macular Disease Society), RNA sensing in endothelial ageing (Leverhulme Trust), and stem cell-microengineering approaches for perfused organoids (BBSRC), reflecting strategic collaborations across vascular science, engineering, and clinical ophthalmology. He directs a multidisciplinary research team advancing vascular repair strategies through stem cell biology and molecular pathway analysis, with particular focus on translating basic discoveries into therapeutic interventions for diabetic vascular complications and age-related eye diseases.

• Vascular Biology
• Ophthalmology
• Diabetes
• +۳ مورد دیگر

Dr. Masahiro Ono is a Reader in Immunology at Imperial College London's Department of Life Sciences, within the Faculty of Natural Sciences. He leads research on T-cell regulation, focusing on autoimmunity, infections, and cancer. His lab pioneered the Tocky system, using Fluorescent Timer proteins to study T-cell activity dynamics in vivo. Dr. Ono holds affiliations with the CRUK Convergence Science Centre, Infection and Immunity, and Integrative Systems Biology. His academic journey includes an MD from Kyoto University (1993-1999) and a PhD in regulatory T cells (2002-2006). He was awarded a HFSP Fellowship (2009) and BBSRC David Phillips Fellowship (2012), establishing his UCL lab before joining Imperial in 2015. Research Interests : Dr. Ono's work bridges immunology, genomics, and systems biology. His lab explores T-cell activation mechanisms, tumor immunology, and bioinformatics tools for single-cell analysis. Key innovations include the Tocky system for real-time cell kinetics tracking and integrative approaches like GatingTree for cytometry data analysis. Awards : HFSP Fellowship (2009) BBSRC David Phillips Fellowship (2012) Grants & Advising : Dr. Ono's grants have supported projects on viral latency, tumor microenvironment modulation, and immune checkpoint therapies. His lab actively collaborates on translational research, though specific grant details are not listed here. Labs & Teams : His lab at Imperial focuses on Tocky-based technologies and interdisciplinary convergence science through the CRUK Centre. Collaborations span virology, oncology, and bioengineering to address unmet clinical needs in immunotherapy.

• Immunology
• Systems Biology
• Genomics
• +۴ مورد دیگر

Professor Michael D. Jenkinson holds the Sir John Fisher / RCS England Chair of Surgical Trials at the University of Liverpool , where he is also Professor of Neurosurgery. His work focuses on meningioma management, brain metastases, and interventional clinical trials, with funding from MRC, Brain Tumour Charity, and NIHR. PhD in Neuroscience (Imaging and Biology of Oligodendroglial Tumours) Consultant Neurosurgeon at The Walton Centre (2010–present) Chief Investigator on NIHR-funded trials: ROAM, STOP 'EM, SPRING, ReStart Research Interests: Meningioma growth modeling and personalized monitoring Seizure prophylaxis in neurosurgery Surgical trials methodology Quality of life assessments in neuro-oncology Leadership Roles: Chair, SBNS Academic Committee Chair, EORTC Meningioma Committee Member, NIHR HTA Prioritisation Committee Co-Investigator on PROSSPER and FUTURE GB trials

• Neurosurgery
• Neuro-Oncology
• Meningioma Management
• +۴ مورد دیگر